Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Gage the current landscape in healthcare and how it might impact therapeutic development in the year ahead. Whats happened in 2018 thus far and what's in the pipeline?
Put your finger on the pulse of public markets in the U.S. and abroad. Examine recent trends, what they mean for deal-making and biotech development.
Driven by a vision to liberate patients from the burden of degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicine that repairs the body when it cannot repair itself.
BlueRock was founded in 2016 when Versant Ventures, a top-tier venture capital firm, and global pharmaceutical giant Bayer AG provided $225 million in Series A financing toward BlueRock’s mission to cure diseases characterized by significant cell loss and diminished ability to self-repair.
Lessons learned,opportunities to take advantage of, obstacles cleared, what to be aware of. What do young biotech companies need to survive and strive in today's landscape? Hear from biotech CEOs across the spectrum of experience and background that are doing it now.